Skip to main content
eScholarship
Open Access Publications from the University of California

Reanalysis of the Rituximab in ANCA-Associated Vasculitis trial identifies granulocyte subsets as a novel early marker of successful treatment

  • Author(s): Butte, Atul
  • Nasrallah, M
  • Pouliot, Y
  • Hartmann, B
  • Dunn, P
  • Thomson, E
  • Wiser, J
  • Butte, AJ
  • et al.

Published Web Location

http://europepmc.org/articles/PMC4576403?pdf=render
No data is associated with this publication.
Abstract

© 2015 Nasrallah et al.Introduction: In the present study, we sought to identify markers in patients with anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) that distinguish those achieving remission at 6 months following rituximab or

Many UC-authored scholarly publications are freely available on this site because of the UC Academic Senate's Open Access Policy. Let us know how this access is important for you.

Item not freely available? Link broken?
Report a problem accessing this item